Epizyme

Epizyme is a biopharmaceutical company focused on the treatment of blood cancer and tumors, mainly engaged in the discovery, development, and planning of commercially innovative personalized treatment solutions for patients with genetic cancers. The company has built a platform for creating 96-member class small molecules that target histone methyltransferases (HMTs). HMTs are part of the gene regulation system, also known as epigenetics, which controls gene expression.